Abstract
The exact relationship between transforming growth factor beta-1 (TGFbeta-1) and the development of chronic graft nephropathy remains uncertain; however, it would appear that TGFbeta-1 is up-regulated at the protein and mRNA levels during the first year following cadaveric renal transplantation and the effect of 'high producer' gene polymorphisms may also be important. This up-regulation of TGFbeta-1 in plasma may provide a novel. non-invasive means of identifying early fibrotic damage before it becomes clinically apparent thus allowing an opportunity for intervention for grafts that may otherwise fail.
Full Text
The Full Text of this article is available as a PDF (175.8 KB).